Partnering With Us
Collaborating to advance pharmaceutical innovation
Acrux has an established track record of developing and commercialising pharmaceutical products through strategic partnerships with international pharmaceutical companies.
Building on our proprietary drug delivery technologies, pharmaceutical development capabilities and regulatory experience, we are focused on collaborations that support the advancement of innovative treatments.
Advancing Women's Health Through Collaboration
Our lead development program, Female Testosterone MDTS, is being developed to address a significant unmet medical need in postmenopausal women with hypoactive sexual desire disorder (HSDD).
Following recent engagement with the US FDA, Acrux is progressing towards Phase III clinical development and advancing discussions with potential co-development partners to support the program's next stage.
Our Commercial Partnerships
Acrux has successfully developed pharmaceutical products commercialised through established international partners, demonstrating our expertise in drug development, licensing and global commercialisation.
Let's Collaborate
We welcome discussions with potential partners interested in advancing innovative pharmaceutical treatments through co-development, licensing and commercialisation opportunities.